| |
| |
|
| Insider
Information: |
Davis George Eric |
| Relationship: |
EVP, Chief Legal Officer |
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
56,157 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,977,195 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
56,157 |
|
|
| Total
Value |
$4,977,195 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Legal Officer |
2024-05-02 |
56,157 |
2007-02-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
223 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 9
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2019-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
9,370 |
86,469 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2019-03-15 |
4 |
D |
$94.53 |
$628,435 |
D/D |
(6,648) |
77,099 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2019-03-19 |
4 |
AS |
$93.92 |
$742,625 |
D/D |
(7,907) |
78,562 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2019-03-22 |
4 |
D |
$88.05 |
$291,357 |
D/D |
(3,309) |
75,253 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2019-03-25 |
4 |
AS |
$87.86 |
$295,473 |
D/D |
(3,363) |
71,890 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2019-04-30 |
4 |
A |
$68.78 |
$21,254 |
D/D |
309 |
72,199 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2019-06-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
300 |
71,899 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2019-11-26 |
4 |
AS |
$79.66 |
$254,115 |
D/D |
(3,190) |
68,709 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2020-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
9,586 |
78,295 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2020-03-13 |
4 |
D |
$84.50 |
$612,118 |
D/D |
(7,244) |
71,051 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2020-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
10,100 |
81,151 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2020-03-20 |
4 |
D |
$73.05 |
$241,722 |
D/D |
(3,309) |
77,842 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2020-04-30 |
4 |
A |
$62.59 |
$21,217 |
D/D |
339 |
78,181 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2020-05-01 |
4 |
AS |
$89.38 |
$1,117,608 |
D/D |
(12,504) |
65,677 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2021-03-15 |
4 |
D |
$78.39 |
$393,047 |
D/D |
(5,014) |
71,083 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2021-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,420 |
76,097 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2021-03-16 |
4 |
D |
$77.21 |
$96,667 |
D/D |
(1,252) |
69,831 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2021-03-22 |
4 |
D |
$78.52 |
$109,221 |
D/D |
(1,391) |
68,440 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2021-04-19 |
4 |
OE |
$26.49 |
$71,761 |
D/D |
2,709 |
71,149 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2021-04-19 |
4 |
AS |
$79.58 |
$215,582 |
D/D |
(2,709) |
68,440 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2021-04-30 |
4 |
A |
$62.41 |
$21,281 |
D/D |
341 |
68,781 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2021-05-03 |
4 |
AS |
$78.30 |
$365,896 |
D/D |
(4,673) |
64,108 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2021-08-02 |
4 |
AS |
$76.69 |
$423,175 |
D/D |
(5,518) |
58,590 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2022-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
9,370 |
67,960 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2022-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
11,040 |
79,000 |
0 |
- |
|
223 Records found
|
|
Page 4 of 9 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
